Horan Securities’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$337K Buy
7,277
+64
+0.9% +$3.14K 0.12% 104
2025
Q1
$440K Buy
7,213
+52
+0.7% +$3.03K 0.17% 74
2024
Q4
$405K Buy
7,161
+85
+1% +$4.75K 0.15% 74
2024
Q3
$366K Sell
7,076
-380
-5% -$17.8K 0.14% 85
2024
Q2
$310K Buy
7,456
+2,104
+39% +$94.1K 0.13% 81
2024
Q1
$290K Buy
5,352
+253
+5% +$12.9K 0.14% 81
2023
Q4
$262K Sell
5,099
-194
-4% -$10.2K 0.13% 83
2023
Q3
$307K Sell
5,293
-113
-2% -$6.92K 0.16% 69
2023
Q2
$346K Buy
5,406
+486
+10% +$32.6K 0.15% 76
2023
Q1
$341K Buy
4,920
+62
+1% +$4.37K 0.18% 62
2022
Q4
$350K Buy
4,858
+788
+19% +$59.4K 0.2% 49
2022
Q3
$289K Sell
4,070
-389
-9% -$28.2K 0.18% 56
2022
Q2
$329K Buy
4,459
+3,988
+847% +$304K 0.2% 47
2022
Q1
$34K Hold
471
0.02% 209
2021
Q4
$29K Buy
+471
New +$27.6K 0.02% 215
2021
Q2
$29K Buy
441
+302
+217% +$19.7K 0.02% 209
2021
Q1
$9K Buy
139
+124
+827% +$7.71K 0.01% 282
2020
Q4
$1K Sell
15
-83
-85% -$5.1K ﹤0.01% 376
2020
Q3
$6K Buy
98
+83
+553% +$5K 0.01% 241
2020
Q2
$1K Buy
+15
New +$897 ﹤0.01% 293

Other funds holding BMY

Horan Securities's BMY Position: Q2 2025 in Review

Horan Securities increased its Bristol-Myers Squibb (BMY) stake by 0.89% in Q2 2025, buying an estimated $3.14K and bringing the position to 7,277 shares worth $337K. The position accounts for 0.12% of the portfolio, ranked #104.

Horan Securities first reported a position in BMY in Q2 2020 and has held it in 20 quarters since. The position peaked at $440K in Q1 2025. 2,297 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Horan Securities held 7,277 shares of Bristol-Myers Squibb worth $337K as of Q2 2025.
  • Horan Securities bought 64 Bristol-Myers Squibb shares in Q2 2025, an estimated $3.14K.
  • Bristol-Myers Squibb made up 0.12% of Horan Securities's portfolio in Q2 2025, its #104 holding.
  • Horan Securities first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 20 quarters since.
  • Horan Securities's Bristol-Myers Squibb position peaked at $440K in Q1 2025.
  • 2,297 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Horan Securities's 13F filing for Q2 2025, filed 6 Aug 2025.